Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 16:30 | 9/30/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Kastelein Johannes Jacob Pieter | DO | Chief Sc | 6 | S.dm | -17,989 | 28.70 | 0 | -627 | 123 | I | ||||||||||||||||
9/9/26 16:30 | 9/4/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Smither John W | D | 1 | S | -41 | 25.32 | 0 | -2 | 9 | D | |||||||||||||||||
7/22/26 16:05 | 7/20/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Kooij Louise Frederika | O | Chief Ac | 10 | S.dm | -21,283 | 31.35 | 0 | -679 | 24 | D | ||||||||||||||||
3/12/26 16:25 | 3/11/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Lange Louis G | P7 | D | 2 | S.d | -2,186 | 30.03 | 0 | -73 | 55 | D | ||||||||||||||||
3/2/26 18:08 | 3/2/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Davidson Michael H. | P7 | DO | CEO | 3 | S.dm | -25,328 | 33.26 | 0 | -762 | 460 | D | |||||||||||||||
1/22/26 17:24 | 1/20/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Somaiya Mayur Ian | P7 | O | CFO | 2 | S.dm | -3,431 | 32.64 | 0 | -105 | 58 | D | |||||||||||||||
7/17/25 17:19 | 7/15/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kling Douglas F | P7 | O | COO | 2 | S.dm | -4,026 | 20.27 | 0 | -199 | 44 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |